Amgen, Gilead beat Street; Dr. Reddy's relieved of ban on Mexico plant;

 @FiercePharma: EU OKs Vertex cystic fibrosis drug Kalydeco. News | Follow @FiercePharma

 @EricPFierce: Judge says no to delaying GSK's buyout of Human Genome Sciences. More | Follow @EricPFierce

>  Share of Amgen ($AMGN) and Gilead Sciences ($GILD), both jumped after they beat Wall Street expectations on earnings. Story

> A federal appeals court on has ruled for two women who developed breast cancer after taking the hormone therapy drug Prempro saying the case needs to be reviewed again by a lower court. Story

> India drugmaker Dr Reddy's Laboratories says the FDA has lifted its import alert on its Mexico-based subsidiary so that it can now begin exporting products to the U.S. from there. Story

> Drug wholesaler McKesson Corp. ($MCK) had a 33% rise in first quarter earnings, driven primarily by revenues from its pharmaceutical distribution business. Story

Medical Device News

@FierceMedDev: The WHO is vetting two circumcision devices designed to slow the spread of HIV in Africa. Story | Follow @FierceMedDev

 @MarkHFierce: Terumo seeks merger deal with Olympus. Will Olympus say yes? More | Follow @MarkHFierce

 @DamianFierce: Despite taking a loss in Q2, Sequenom is forging ahead with its Down syndrome Dx. News | Follow @DamianFierce

> Roche sells more Dx equipment, fewer diabetes products in H1 2012. Article

> Depression-treating device tests well in everyday clinical practice use. Item

Biotech News

 @FierceBiotech: Covance takes a $12.7M loss in Q2. More | Follow @FierceBiotech

 @JohnCFierce: A majority of FDA experts vote for approval of ThromboGenics' eye drug ocriplasmin. Post-OK study would be "nice." Report | Follow @JohnCFierce

 @RyanMFierce: EU approval of Vertex's Kalydeco in cystic fibrosis comes 7 months after FDA stamp. Release | Follow @RyanMFierce

> ThromboGenics wins FDA panel nod for eye drug. News

> Analysts: Ailing Elan casts buyout bait for Biogen Idec. Report

> Buzz: HGS passed up $7B Amgen bid back in the day. Story

> FDA OKs Amarin's blockbuster heart drug contender AMR101. Article

> FDA green-lights Horizon Pharma's Rayos. More

And Finally... Researcher have said that treatments appear to have cleared two men of the HIV virus, raising the possibility of a cure for the disease. Story